テキサスにおけるB細胞白血病の臨床試験
テキサス内の拠点で、B細胞白血病に関する12件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06542250Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT04728893Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
被験者募集中第1相
75歳以下 · 全性別 · 2026/09/16更新 · NCT06345027A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Research Site, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06564038Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Houston
被験者募集中第3相
18歳〜18歳 · 全性別 · 2026/09/08更新 · NCT07509151Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
- Texas Children's Hospital, Houston
被験者募集中第1相
12 Months – 25 Years · 全性別 · 2026/09/04更新 · NCT05010564Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- University of Texas, Southwestern, Dallas
- Baylor Texas Children's Hospital, Houston
被験者募集中第2相
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Lumi Research, Kingwood
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05254743A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
- UT Southwestern Medical Center, Dallas
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
被験者募集中第1/2相
12歳〜95歳 · 全性別 · 2026/04/15更新 · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Ut Southwestern, Dallas
被験者募集中観察研究
全年齢 · 全性別 · 2026/01/22更新 · NCT06357754ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。